Walleye Capital
ESLAW icon

Walleye Capital’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Walleye Capital’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,330
Closed -$908 – 4473
2024
Q4 		$908 Sell
10,330
-55,782
-84% -$4.75K ﹤0.01% 4708
2024
Q3 		$4.63K Hold
66,112
– – ﹤0.01% 4999
2024
Q2 		$4.56K Hold
66,112
– – ﹤0.01% 5331
2024
Q1 		$4.39K Hold
66,112
– – ﹤0.01% 5174
2023
Q4 		$1.98K Buy
+66,112
New +$5.15K ﹤0.01% 4763

Other funds holding ESLAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Walleye Capital's ESLAW Position: Q1 2025 in Review

Walleye Capital sold out of Estrella Immunopharma Warrant (ESLAW) in Q1 2025, closing a stake of 10,330 shares — an estimated $908 sold.

Walleye Capital first reported a position in ESLAW in Q4 2023 and held it in 5 quarters. The position peaked at $4.63K in Q3 2024. 10 funds tracked by Wall St. Rank hold ESLAW as of Q1 2025.

  • Walleye Capital reported no remaining Estrella Immunopharma Warrant position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 10,330 Estrella Immunopharma Warrant shares in Q1 2025, an estimated $908.
  • Walleye Capital first reported a position in Estrella Immunopharma Warrant in Q4 2023 and held it in 5 quarters.
  • Walleye Capital's Estrella Immunopharma Warrant position peaked at $4.63K in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.